Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Betamethasone and Severity of Hyaline Membrane Disease in the Newborn Premature

NCT01854840 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT01854840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01854840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Betamethasone and Severity of Hyaline Membrane Disease in the Newborn Premature
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Observational
Overall status
Completed
Start date
January 12, 2012
Completion date
December 31, 2018
Enrollment
127 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnant women receive celesten